Wire · opportunities
Novo & Anthropic: Partnering on Claude AI Drug Discovery
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 18 September 2026 · Fusion42 review
Novo, a Danish drugmaker, has partnered with US AI lab Anthropic to utilize the Claude AI model for drug discovery, aiming to accelerate research timelines and improve development outcomes. The collaboration focuses on addressing key drug discovery challenges through AI-driven scientific reasoning and software development.
This Wire brief sits within Fusion42's coverage of Biotech, and 8 sources have reported it between 16 Sep 2026 and 22 Sep 2026.
◆ ◆ The Wire takeaway
Your biotech R&D can now move faster with Claude AI helping cut traditional timelines in drug development. You should explore integrating advanced AI models to enhance research speed and precision, as Novo and Anthropic have opened this route.
◆ Coverage
8 sources · first reported 16 Sep 2026 · latest 22 Sep 2026
◆ Topics